Issue 7, 2024

Correction: Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents

Abstract

Correction for ‘Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents’ by Zhen Wang et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d4md00053f.

Associated articles

Article information

Article type
Correction
Submitted
03 Jun 2024
Accepted
03 Jun 2024
First published
17 Jun 2024
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2024,15, 2570-2571

Correction: Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents

Z. Wang, J. Zhang, C. Gai, J. Wang, X. Zhuo, Y. Song, Y. Zou, P. Zhang, G. Hou, Q. Meng, Q. Zhao and X. Chai, RSC Med. Chem., 2024, 15, 2570 DOI: 10.1039/D4MD90023E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements